Skip to main content

. 1987 Oct;50(10):1387. doi: 10.1136/jnnp.50.10.1387

Double-blind controlled trial of azathioprine in the treatment of multiple sclerosis.

PMCID: PMC1032473 PMID: 3316505

1387

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Hauser S. L., Dawson D. M., Lehrich J. R., Beal M. F., Kevy S. V., Propper R. D., Mills J. A., Weiner H. L. Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH. N Engl J Med. 1983 Jan 27;308(4):173–180. doi: 10.1056/NEJM198301273080401. [DOI] [PubMed] [Google Scholar]
Kurtzke J. F. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983 Nov;33(11):1444–1452. doi: 10.1212/wnl.33.11.1444. [DOI] [PubMed] [Google Scholar]
Patzold U., Hecker H., Pocklington P. Azathioprine in treatment of multiple sclerosis. Final results of a 41/2-year controlled study of its effectiveness covering 115 patients. J Neurol Sci. 1982 Jun;54(3):377–394. doi: 10.1016/0022-510x(82)90201-5. [DOI] [PubMed] [Google Scholar]
Swinburn W. R., Liversedge L. A. Long-term treatment of multiple sclerosis with azathioprine. J Neurol Neurosurg Psychiatry. 1973 Feb;36(1):124–126. doi: 10.1136/jnnp.36.1.124. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES